drugset / Trial / NCT01219738

Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide

NCT01219738

RandomizedSingle-groupDouble-blindBasic science

Summary

Glucocorticosteroids recently have been shown to have non-genomic actions that are plasma membrane-mediated and do not require gene transcription and translation. One of these non-genomic effects is the inhibition of adrenergic agonist transport into airway vascular smooth muscle cells with an increase of adrenergic agonist concentrations at adrenergic receptor sites and enhance the physiological effects of endogenous adrenergic agonists (e.g. locally released norepinephrine from noradrenergic neurons) or exogenous adrenergic agonists (e.g. inhaled beta-adrenergic agonists).

Timeline

Start
2008-07
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 360 ug Inhaled
Subject Budesonide Small molecule 720 ug Inhaled
Subject Budesonide Small molecule 1440 ug Inhaled

Indications